Overview
Modern Fertility, a subsidiary of Ro, represents a paradigm shift in reproductive healthcare by decentralizing clinical laboratory testing. The platform's technical core utilizes a proprietary algorithm that normalizes finger-prick blood samples against traditional venipuncture results, ensuring laboratory-grade precision for at-home kits. As of 2026, the service has evolved into a comprehensive digital health ecosystem. It processes bio-data across seven key hormones: Antimüllerian Hormone (AMH), Follicle-Stimulating Hormone (FSH), Estradiol (E2), Luteinizing Hormone (LH), Thyroid-Stimulating Hormone (TSH), Prolactin (PRL), and Testosterone. The architecture leverages a HIPAA-compliant cloud infrastructure to deliver personalized 'Fertility Profiles.' These profiles use machine learning to synthesize diagnostic data with user-reported lifestyle factors, providing longitudinal health tracking and predictive modeling for conception windows and menopause onset. By integrating with the broader Ro telehealth network, Modern Fertility facilitates a seamless transition from at-home diagnostics to professional clinical consultation, making it a critical player in the 2026 personalized medicine market.